STOCK TITAN

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Haemonetics Corporation (NYSE: HAE) has announced that President and CEO Chris Simon will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference. The event is scheduled for Monday, June 9, 2025, at 8:40 a.m. ET. Investors and the public can access the live webcast through Haemonetics' Investor Relations website or via a provided direct link. A replay of the webcast will be made available 12 hours after the event and will remain accessible for 90 days on the company's Investor Relations website.
Haemonetics Corporation (NYSE: HAE) ha annunciato che il Presidente e CEO Chris Simon parteciperà a una conversazione informale con gli investitori durante la 46ª Conferenza Globale Annuale sulla Sanità di Goldman Sachs. L'evento è previsto per lunedì 9 giugno 2025 alle 8:40 ET. Investitori e pubblico potranno seguire la diretta streaming tramite il sito web delle Relazioni con gli Investitori di Haemonetics o tramite un link diretto fornito. La registrazione della diretta sarà disponibile 12 ore dopo l'evento e resterà accessibile per 90 giorni sul sito delle Relazioni con gli Investitori dell'azienda.
Haemonetics Corporation (NYSE: HAE) ha anunciado que el presidente y CEO Chris Simon participará en una charla informal con inversores durante la 46ª Conferencia Global Anual de Salud de Goldman Sachs. El evento está programado para el lunes 9 de junio de 2025 a las 8:40 a.m. ET. Los inversores y el público podrán acceder a la transmisión en vivo a través del sitio web de Relaciones con Inversores de Haemonetics o mediante un enlace directo proporcionado. La repetición de la transmisión estará disponible 12 horas después del evento y permanecerá accesible durante 90 días en el sitio web de Relaciones con Inversores de la empresa.
Haemonetics Corporation(NYSE: HAE)는 사장 겸 CEO인 크리스 사이먼이 골드만삭스 제46회 연례 글로벌 헬스케어 컨퍼런스에서 투자자들과의 대화에 참여할 것이라고 발표했습니다. 행사는 2025년 6월 9일 월요일 동부시간 오전 8시 40분에 예정되어 있습니다. 투자자와 일반인은 Haemonetics 투자자 관계 웹사이트 또는 제공된 직접 링크를 통해 생중계에 접속할 수 있습니다. 생중계 녹화는 행사 종료 12시간 후에 제공되며, 회사의 투자자 관계 웹사이트에서 90일간 시청할 수 있습니다.
Haemonetics Corporation (NYSE : HAE) a annoncé que le président-directeur général Chris Simon participera à une discussion informelle avec les investisseurs lors de la 46e conférence annuelle mondiale sur la santé de Goldman Sachs. L'événement est prévu pour le lundi 9 juin 2025 à 8h40, heure de l'Est. Les investisseurs et le public pourront accéder à la diffusion en direct via le site web des relations investisseurs de Haemonetics ou par un lien direct fourni. La rediffusion sera disponible 12 heures après l'événement et restera accessible pendant 90 jours sur le site des relations investisseurs de l'entreprise.
Haemonetics Corporation (NYSE: HAE) hat angekündigt, dass Präsident und CEO Chris Simon an einem Gespräch mit Investoren im Rahmen der 46. jährlichen globalen Gesundheitskonferenz von Goldman Sachs teilnehmen wird. Die Veranstaltung findet am Montag, den 9. Juni 2025, um 8:40 Uhr ET statt. Investoren und die Öffentlichkeit können den Live-Webcast über die Investor-Relations-Website von Haemonetics oder über einen bereitgestellten Direktlink verfolgen. Eine Wiederholung des Webcasts wird 12 Stunden nach der Veranstaltung verfügbar sein und für 90 Tage auf der Investor-Relations-Website des Unternehmens abrufbar bleiben.
Positive
  • None.
Negative
  • None.

BOSTON, May 30, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 8:40 a.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://event.webcasts.com/starthere.jsp?ei=1721260&tp_key=3096fdc651&tp_special=8

A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:     
Olga Guyette, Vice President-Investor Relations & Treasury     
(781) 356-9763   
olga.guyette@haemonetics.com 

David Trenk, Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com                                                                               

Media Contact:       
Josh Gitelson, Sr. Director-Global Communications   
(781) 356-9776
josh.gitelson@haemonetics.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-goldman-sachs-46th-annual-global-healthcare-conference-302468741.html

SOURCE Haemonetics Corporation

FAQ

When is Haemonetics (HAE) presenting at the Goldman Sachs Healthcare Conference 2025?

Haemonetics will present at the Goldman Sachs Healthcare Conference on Monday, June 9, 2025 at 8:40 a.m. ET.

Who will represent Haemonetics (HAE) at the Goldman Sachs Healthcare Conference?

Chris Simon, President and CEO of Haemonetics, will represent the company at the conference.

How can investors access Haemonetics' (HAE) presentation at the Goldman Sachs conference?

Investors can access the live webcast through Haemonetics' Investor Relations website or via a provided direct link.

How long will the replay of Haemonetics' (HAE) Goldman Sachs conference presentation be available?

The replay will be available for 90 days on Haemonetics' Investor Relations website, accessible 12 hours after the event.
Haemonetics Corp Mass

NYSE:HAE

HAE Rankings

HAE Latest News

HAE Stock Data

3.18B
47.53M
0.89%
115.54%
12.88%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
BOSTON